Back

Role of immunosuppression in patients with lymphocytic myocarditis and myocardial parvovirus B19 with or without human herpesvirus 6 co-presence

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Myocarditis: still many open questions Myocarditis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ahmed Elsanhoury

Charite University Hospital, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Impact of myocardial injury on mortality and adverse events in hospitalized patients with influenza: a prospective cohort study
Doctor A. Valotta (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Prevalence and characteristics of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the Study
Doctor R. Colleran (Dublin 7, IE)
Abstract Slides Video
Presentation thumbnail
Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.
Doctor M. Sadler (London, GB)
Abstract Slides Video
Presentation thumbnail
Genetic characterization of biopsy-proven myocarditis: a pilot study
Doctor M. Bueno Marinas (Padova, IT)
Abstract Slides Video
Presentation thumbnail
SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population
Doctor C. Greer (Christchurch, NZ)
Abstract Slides Video

Access the full session

Session thumbnail
Myocarditis: still many open questions

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
A case of an acute fulminant myocarditis-induced cardiogenic shock with biopsy-evident massive CD3+ T and CD20+ B lymphocytic infiltrates and detection of B19V- and EBV-genome
thumbnail
Congress Presentation
Medical therapy for inflammatory myopericardial syndrome
thumbnail
Congress Presentation
Long-term efficacy of tailored prolonged immunosuppressive therapy in biopsy-proven virus- negative myocarditis: a single center propensity weighted study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources